Output Biosciences develops biologically-aware generative AI to create large biological models for advancing medicine and improving health outcomes.
Founded
2021
Company Stage
Pre-Seed
YC Batch
S21
Product Features & Capabilities
Drug Discovery, Biological Data Modeling, Systems Biology, Disease Modeling, Pharmaceutical Research, Drug Candidate Generation, Comprehensive Biological Integration, AI-Enabled Biological Tasks
How much Output Biosciences raised
Pre-Seed - $125,000
August 22, 2021
Lead Investor: Y Combinator, Able Partners, First Round Capital, Great Oaks Venture Capital